The pharmacopeial perspective in accelerating the development and availability of biologicals and biotechnological-derived products
Williams, R.L.
Developments in Biologicals 109: 137-142
2002
ISSN/ISBN: 1424-6074 PMID: 12434923 Document Number: 548561
Document emailed within 1 workday
Related Documents
Ruiz Antúnez, M.S. 1999: Biotechnological products and gene therapy. what are we talking about? Methods and Findings in Experimental and Clinical Pharmacology 21 Suppl B: 7Gay, C.G. 1992: Current USDA procedures for licensing biotechnology-derived veterinary biologicals Developments in Biological Standardization 79: 65-74
Toni, R.; Casa, C.Della.; Spaletta, G.; Marchetti, G.; Mazzoni, P.; Bodria, M.; Ravera, S.; Dallatana, D.; Castorina, S.; Riccioli, V.; Castorina, E.Giovanni.; Antoci, S.; Campanile, E.; Raise, G.; Scalise, G.; Rossi, R.; Rossio, R.; Ugolotti, G.; Ugolottio, G.; Martorella, A.; Roti, E.; Rot, E.; Sgallari, F.; Pinchera, A. 2007: The bioartificial thyroid: a biotechnological perspective in endocrine organ engineering for transplantation replacement Acta Bio-Medica: Atenei Parmensis 78(Suppl 1): 129-155
Brodniewicz-Proba, T. 2008: The scope and requirements related to preclinical and clinical studies of a new medicinal product, including biotechnological and biosimilar products Acta Poloniae Pharmaceutica 65(6): 641-645
Abramovich, R.A.; Bykov, V.A.; Elagina, I.A.; Papazova, N.A.; Vorob'ev, A.N. 2012: Scientific approaches to development of medicinal formulation based on biotechnological substance Antibiotiki i Khimioterapiia 57(1-2): 13-16
Müller, F.O.; Steyn, J.M.; Hundt, H.K.; Luus, H.G. 1988: Warfarin bio-availability. a comparison of 4 products South African Medical Journal 74(11): 566-567
Yasuhiro Murota; Kokichi Ito 1996: Global warming and developing countries: The possibility of a solution by accelerating development Energy Policy 24(12): 1061-1077
Excler, J-Louis.; Pitisuttithum, P.; Rerks-Ngarm, S.; Shao, Y.; Zhang, L.; Tamashiro, H.; Osmanov, S.; Abimiku, A'le.; Barnett, S.W.; Ditangco, R.A.; Dong, X-Ping.; Esparza, J.; Excler, J-Louis.; Nguyen, T.Hien.; Kelleher, T.; Kim, D.; Kim, J.; Kripke, K.; Lasher, H.; Levy, Y.; Mathieson, B.; Matsuo, K.; Mean, C.Vun.; Nguyen, T.Hien.Thanh.; Olveda, R.M.; Phimphachanh, C.; Pitisuttithum, P.; Rerks-Ngarm, S.; Shao, Y.; Tamashiro, H.; Thanprasertsuk, S.; Vun, M.Chhi.; Warren, M.; Yamamoto, N.; Yamamoto, T.; Yamazaki, S.; Zhang, L.; Osmanov, S.; Excler, J-Louis.; Tamashiro,; 2008: Expanding research capacity and accelerating AIDS vaccine development in Asia Southeast Asian Journal of Tropical Medicine and Public Health 39(4): 766-784
Yasuhiro Murota; Kokichi Ito 1996: Global warming and developing countries: The possibility of a solution by accelerating development Energy Policy 24(12): 1061-1077
Niimi, S. 2015: Development of guidance for the approval process of brand-new medical products and regenerative medicine products Kokuritsu Iyakuhin Shokuhin Eisei Kenkyujo Hokoku 133: 1-7
Tholhuijsen, L. 2000: Sellers of products derived from animals Tijdschrift Voor Diergeneeskunde 125(14): 469
Fabio, S. di; Cianfriglia, M.; Flego, M.; Ascione, A.; Gellini, M.; Zamboni, S.; Binelli, A.; Carlini, F.; Germinario, E.; Vella, S. 2006: Animal HU-SCID model of vaginal transmission of HIV-1 for the preclinical evaluation of microbicides. Development of peptidomimetics and mini-antibodies as a new class of microbicides of biotechnological origin Rapporti ISTISAN Istituto Superiore di Sanita (06/50): 298-301
Menne, B.; Aragon de Leon, E.; Bekker, M.; Mirzikashvili, N.; Morton, S.; Shriwise, A.; Tomson, G.ör.; Vracko, P.; Wippel, C. 2020: Health and well-being for all: an approach to accelerating progress to achieve the Sustainable Development Goals (SDGs) in countries in the WHO European Region European Journal of Public Health 30(Suppl_1): I3-I9
Rosenhouse, S. 2001: Accelerating the development of an AIDS vaccine for developing countries An example of mechanisms available to the World Bank to increase investment in public goods AIDS 15(Suppl 1): S47
Rosenhouse, S. 2001: Accelerating the development of an AIDS vaccine for developing countries An example of mechanisms available to the World Bank to increase investment in public goods AIDS 15(Suppl 1): S47
Rosenhouse, S. 2001: Accelerating the development of an AIDS vaccine for developing countries An example of mechanisms available to the World Bank to increase investment in public goods AIDS 15(Suppl 1): S47
Shields, E.D. 1999: A new perspective of human origin and dispersals derived from the microevolution of teeth Journal of Craniofacial Genetics and Developmental Biology 19(3): 119-127
Alam, A.Y. 2017: The challenge of dealing with animal derived ingredients in medical/surgical products JPMA. Journal of the Pakistan Medical Association 67(11): 1646-1647
Mínguez-Mosquera, M.I.; Hornero-Méndez, D.; Garrido-Fernández, J. 1995: Detection of bixin, lycopene, canthaxanthin, and beta-apo-8'-carotenal in products derived from red pepper Journal - Association of Official Analytical Chemists 78(2): 491-496
Palladino, M.A.; Levinson, A.D.; Svedersky, L.P.; Obijeski, J.F. 1987: Safety issues related to the use of recombinant DNA-derived cell culture products. I. Cellular components Developments in Biological Standardization 66: 13-22